Jiangsu Tohope Pharmaceutical

Jiangsu Tohope Pharmaceutical is a Chinese pharmaceutical and health-products manufacturer focused on active pharmaceutical ingredients (APIs) and health food products. The company presents itself as a leading Chinese producer of alpha lipoic acid and a major global supplier of that ingredient, with more than 30 years of chemical manufacturing experience. Its business appears centered on commercial manufacturing rather than innovative clinical-stage drug development, with products spanning alpha lipoic acid and selected additional APIs and intermediates such as carbamazepine, metformin hydrochloride, tauroursodeoxycholic acid, and capecitabine-related manufacturing scope. The company emphasizes GMP-compliant production, quality systems, and a newer factory in Changshu that passed an NMPA GMP compliance inspection in the first half of 2023. Overall, Jiangsu Tohope Pharmaceutical looks most like an established commercial API and nutraceutical producer serving domestic and export markets rather than a pipeline-driven biotech.